0DKX Stock Overview
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
Aedifica NV/SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €60.69 |
| 52 Week High | €76.50 |
| 52 Week Low | €47.18 |
| Beta | 0.83 |
| 1 Month Change | 11.88% |
| 3 Month Change | 3.50% |
| 1 Year Change | -16.82% |
| 3 Year Change | -41.55% |
| 5 Year Change | -23.67% |
| Change since IPO | 57.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0DKX | GB Health Care REITs | GB Market | |
|---|---|---|---|
| 7D | 5.4% | -0.7% | -0.9% |
| 1Y | -16.8% | -14.2% | -1.8% |
Return vs Industry: 0DKX underperformed the UK Health Care REITs industry which returned -14.2% over the past year.
Return vs Market: 0DKX underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| 0DKX volatility | |
|---|---|
| 0DKX Average Weekly Movement | 2.9% |
| Health Care REITs Industry Average Movement | 2.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0DKX has not had significant price volatility in the past 3 months.
Volatility Over Time: 0DKX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 127 | Mrics Gielens | www.aedifica.eu |
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 620 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Sweden, Ireland and Spain, worth more than €5.8 billion.
Aedifica NV/SA Fundamentals Summary
| 0DKX fundamental statistics | |
|---|---|
| Market cap | €2.88b |
| Earnings (TTM) | €24.54m |
| Revenue (TTM) | €321.11m |
117.4x
P/E Ratio9.0x
P/S RatioIs 0DKX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0DKX income statement (TTM) | |
|---|---|
| Revenue | €321.11m |
| Cost of Revenue | €19.65m |
| Gross Profit | €301.47m |
| Other Expenses | €276.93m |
| Earnings | €24.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 0.52 |
| Gross Margin | 93.88% |
| Net Profit Margin | 7.64% |
| Debt/Equity Ratio | 64.0% |
How did 0DKX perform over the long term?
See historical performance and comparisonDividends
6.4%
Current Dividend Yield51%
Payout RatioDoes 0DKX pay a reliable dividends?
See 0DKX dividend history and benchmarks| Aedifica/SA dividend dates | |
|---|---|
| Ex Dividend Date | May 16 2024 |
| Dividend Pay Date | May 22 2024 |
| Days until Ex dividend | 22 days |
| Days until Dividend pay date | 28 days |
Does 0DKX pay a reliable dividends?
See 0DKX dividend history and benchmarks